Janus Henderson Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Hold |
21,300
| – | – | ﹤0.01% | 2377 |
|
|
2025
Q1 | $172K | Sell |
21,300
-1,284,920
| -98% | -$10.4M | ﹤0.01% | 2398 |
|
|
2024
Q4 | $16.6M | Sell |
1,306,220
-870,977
| -40% | -$11M | 0.01% | 625 |
|
|
2024
Q3 | $30.3M | Buy |
2,177,197
+337,928
| +18% | +$4.7M | 0.02% | 493 |
|
|
2024
Q2 | $25.4M | Sell |
1,839,269
-193,115
| -10% | -$2.66M | 0.01% | 522 |
|
|
2024
Q1 | $33.6M | Buy |
2,032,384
+336,281
| +20% | +$5.56M | 0.02% | 461 |
|
|
2023
Q4 | $24.8M | Buy |
1,696,103
+874,650
| +106% | +$12.8M | 0.01% | 505 |
|
|
2023
Q3 | $10.1M | Buy |
821,453
+133,943
| +19% | +$1.64M | 0.01% | 662 |
|
|
2023
Q2 | $8.21M | Buy |
687,510
+124,716
| +22% | +$1.49M | 0.01% | 730 |
|
|
2023
Q1 | $7.53M | Buy |
+562,794
| New | +$7.53M | 0.01% | 768 |
|
|
2022
Q2 | – | Sell |
-902,020
| Closed | -$8.95M | – | 2617 |
|
|
2022
Q1 | $8.95M | Sell |
902,020
-120,528
| -12% | -$1.2M | ﹤0.01% | 908 |
|
|
2021
Q4 | $16.6M | Buy |
1,022,548
+65
| +0% | +$1.06K | 0.01% | 831 |
|
|
2021
Q3 | $23.4M | Sell |
1,022,483
-275,287
| -21% | -$6.3M | 0.01% | 756 |
|
|
2021
Q2 | $27.9M | Buy |
+1,297,770
| New | +$27.9M | 0.01% | 715 |
|